# The Public Health Company Group

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/the-public-health-company-group

- Industry: Biotechnology
- Headquarters: US
- Website: www.thepublichealthco.com
- Total disclosed funding: $8M
- Latest round: Seed (Apr 29, 2021)
- Investors on record: 3

## About

The Public Health Company Group, Inc. focuses on innovative biodefense solutions, providing essential intelligence to detect and manage biological threats for diverse clients.Founded in 2020 and headquartered in the US, The Public Health Company Group, Inc. specializes in biothreat intelligence solutions. Founder Charity Dean has a background in public health and has led the company through its initial funding round. The company raised USD 8.00 mn in a Seed funding round on April 29, 2021, led by Venrock, with contributions from Sweat Equity Ventures and Verily Life Sciences LLC.Building the Future of Biodefense specializes in biothreat intelligence solutions designed to deter and detect various biological agents, including natural, accidental, deliberate, and novel threats. The company's core offerings, PHC Navigator and PHC Vector, leverage expert-curated and proprietary data to provide actionable intelligence and insights. PHC Navigator functions as an advanced biothreat intelligence engine, while PHC Vector offers direct programmatic access to the company’s intelligence, simplifying the complex biodefense landscape for end users. The services cater to a wide range of clients including government agencies, healthcare organizations, military facilities, and corporations seeking to enhance their biological risk assessment and response capabilities. Geographically, these products are marketed in the United States and internationally, addressing the needs of clients in regions facing significant biothreat concerns and those involved in biodefense operations.Revenue generation for Building the Future of Biodefense primarily occurs through subscription-based models for its products, where clients pay for access to the advanced intelligence provided by PHC Navigator and PHC Vector. Clients typically enter into partnerships that involve annual contracts or multi-year agreements, ensuring continuous access to up-to-date intelligence and support services. The structure of these transactions is B2B, with clients ranging from government entities to private organizations focused on public health and safety. Specific pricing plans for the services, including flagship offerings like PHC Navigator, reflect the complexity and scope of the solutions provided, catering to varied client needs while enhancing their biodefense capabilities.The Public Health Company Group, Inc. plans to utilize the USD 8.00 mn raised from the most recent Seed funding round in April 2021 to support the development of new products and expansion into additional markets. The company aims to enhance its biothreat intelligence offerings and is targeting growth in international markets, with specific plans to enter regions facing high biological risks by 2023. Recent funding will facilitate these initiatives and support the ongoing development of innovative biodefense solutions.

## Funding rounds

- Seed, Apr 29, 2021, $8M — Venrock, Verily Life Sciences LLC, Sweat Equity Ventures

## Investors

- Venrock (https://capitalatlas.ai/funds/venrock) — Seed
- Verily Life Sciences LLC — Seed
- Sweat Equity Ventures (https://capitalatlas.ai/funds/sweat-equity-ventures) — Seed